MO vs REGN · P/E 14, rev $23.28B vs P/E 14, rev $14.34B
Altria Group (MO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Altria Group (MO) is a tobacco company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MO currently screens at market cap $115.14B and trailing P/E 14.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MO and REGN stock pages for the full models.
Not investment advice.